Immunome IMNM
NASDAQ IMNM
$18.00 +0.08 (+0.45%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immunome (IMNM) Preferred Dividend Payments (2022)

Updated

Immunome (IMNM) reported Preferred Dividend Payments of $622,000 for FY2022.

Analysis

Immunome (IMNM) Preferred Dividend Payments (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Immunome 2.04 Bn 11.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 622,000.00
API Access

Immunome Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=IMNM&period=max&api_key=YOUR_API_KEY